We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+6.89%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$9.83B
AUM Growth
+$1.07B
Cap. Flow
-$195M
Cap. Flow %
-1.98%
Top 10 Hldgs %
25.87%
Holding
1,420
New
446
Increased
141
Reduced
120
Closed
281

Top Buys

Rank Stock Value
1
HDB icon
HDFC Bank
HDB
+$63.2M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
GSK icon
GSK
GSK
+$50.8M
4
INFY icon
Infosys
INFY
+$49.3M
5
APH icon
Amphenol
APH
+$46M

Top Sells

Rank Stock Value
1
TFC icon
Truist Financial
TFC
+$61.3M
2
NTRS icon
Northern Trust
NTRS
+$59.7M
3
NVDA icon
NVIDIA
NVDA
+$58M
4
CACC icon
Credit Acceptance
CACC
+$53.9M
5
BHP icon
BHP
BHP
+$45.2M

Sector Composition

Rank Sector Weight
1 Technology 9.1%
2 Healthcare 3.88%
3 Consumer Staples 2.93%
4 Energy 2.82%
5 Financials 2.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEC
851
Diversified Energy Company
DEC
$878M
$163K ﹤0.01%
+13,551
New +$170K
ROIV icon
852
CALL
Roivant Sciences
ROIV
$25B
$160K ﹤0.01%
+15,200
New +$164K
CCCC icon
853
C4 Therapeutics
CCCC
$397M
$160K ﹤0.01%
+19,563
New +$152K
ABUS icon
854
Arbutus Biopharma
ABUS
$871M
$155K ﹤0.01%
60,000
DFTX
855
Definium Therapeutics
DFTX
$5.66B
$154K ﹤0.01%
+16,374
New +$93.4K
CTLT
856
DELISTED
CATALENT, INC.
CTLT
$152K ﹤0.01%
+2,701
New +$146K
LILMW
857
DELISTED
Lilium N.V. Warrants
LILMW
$147K ﹤0.01%
1,702,687
BFLY.WS
858
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$144K ﹤0.01%
3,188,004
AAOI icon
859
Applied Optoelectronics
AAOI
$7.85B
$142K ﹤0.01%
+10,267
New +$173K
CATX icon
860
Perspective Therapeutics
CATX
$322M
$137K ﹤0.01%
+11,549
New +$98.5K
QVCGA
861
DELISTED
QVC Group Inc Series A
QVCGA
$137K ﹤0.01%
+2,220
New +$116K
GETY icon
862
Getty Images
GETY
$173M
$136K ﹤0.01%
+32,683
New +$151K
SLDPW icon
863
Solid Power Inc Warrant
SLDPW
$9.12M
$132K ﹤0.01%
650,228
SST.WS
864
DELISTED
System1, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SST.WS
$131K ﹤0.01%
902,720
HNST icon
865
The Honest Company
HNST
$423M
$127K ﹤0.01%
+31,313
New +$106K
PRCH icon
866
Porch Group
PRCH
$1.39B
$127K ﹤0.01%
+29,388
New +$87.6K
MVSTW
867
DELISTED
Microvast Holdings Warrants
MVSTW
$126K ﹤0.01%
1,181,416
URG
868
Ur-Energy
URG
$489M
$126K ﹤0.01%
+78,694
New +$131K
BZFDW icon
869
BuzzFeed Inc Warrant
BZFDW
$763K
$126K ﹤0.01%
2,807,585
PSFE.WS
870
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$123K ﹤0.01%
3,897,840
ABSI icon
871
Absci
ABSI
$1.28B
$122K ﹤0.01%
+21,494
New +$96.9K
UP icon
872
Wheels Up
UP
$219M
$121K ﹤0.01%
+2,102
New +$138K
EVEX.WS icon
873
Eve Holding Inc Warrants
EVEX.WS
$45.1M
$116K ﹤0.01%
217,200
ARQQW icon
874
Arqit Quantum Warrants
ARQQW
$204K
$114K ﹤0.01%
542,846
TALK icon
875
Talkspace
TALK
$874M
$113K ﹤0.01%
+31,637
New +$86K

Similar funds

LMR Partners's Q1 2024 Portfolio in Review

As of Q1 2024, LMR Partners held 1,420 positions worth $9.83B, up 12% from $8.76B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

LMR Partners's Q1 2024 filing shows 446 new, 141 increased, 120 reduced and 281 closed positions. Its largest new stake was GSK: 1,232,283 shares worth $52.8M. The largest sale was Truist Financial, an estimated $61.3M.

By sector, the portfolio is most concentrated in Technology at 9.1% of assets, up from 5.9% a quarter earlier, followed by Healthcare and Consumer Staples.

  • LMR Partners's largest Q1 2024 buy was GSK: 1,232,283 shares worth $52.8M.
  • LMR Partners added most to HDFC Bank in Q1 2024, an estimated $63.2M increase.
  • LMR Partners's biggest Q1 2024 reduction was Credit Acceptance, cutting an estimated $53.9M.
  • LMR Partners fully exited Truist Financial in Q1 2024, selling an estimated $61.3M.
  • LMR Partners's ten largest holdings make up 26% of its $9.83B portfolio in Q1 2024.
  • LMR Partners opened 446 new positions and closed 281 in Q1 2024.
  • LMR Partners's portfolio value rose 12% quarter-over-quarter to $9.83B.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.